US FDA uncertain about supply timeline of Novo Nordisk's weight loss drug

2Seventy Bio

12/09/2023 16:46

Sept 12 (Reuters) - U.S. Food and Drug Administration on
Tuesday changed its estimate for the availability of lower doses
of Novo Nordisk's  NOVOb.CO  weight-loss drug Wegovy to "to be
decided" from its earlier expectation of September.

 (Reporting by Leroy Leo in Bengaluru; Editing by Shinjini
Ganguli)
 ((Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7;))